Dual Antiplatelet Alternatives are Associated with Increased Stroke and Death after Transcarotid Revascularization.

Hanaa Dakour-AridiRaghu L MotaganahalliAndres FajardoAkiko TanakaNaveed U SaqibGordon H MartinAleem MirzaArash KeyhaniKourosh KeyhaniShihuan Keisin Wang

Published in: Annals of surgery (2022)

Patients not maintained on DAPT after TCAR experienced increased risk of stroke and death in the perioperative and follow-up periods. Increased surgeon vigilance is required to ensure compliance with dual antiplatelets as recommended.

Keyphrases

atrial fibrillation
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
percutaneous coronary intervention
acute kidney injury
brain injury